On Friday, SpringWorks Therapeutics Inc (NASDAQ: SWTX) was 0.07% up from the session before settling in for the closing price of $46.08. A 52-week range for SWTX has been $28.21 – $62.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 663.47%. When this article was written, the company’s average yearly earnings per share was at 20.99%. With a float of $72.93 million, this company’s outstanding shares have now reached $74.99 million.
Let’s determine the extent of company efficiency that accounts for 368 employees. In terms of profitability, gross margin is 93.23%, operating margin of -120.52%, and the pretax margin is -115.6%.
SpringWorks Therapeutics Inc (SWTX) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SpringWorks Therapeutics Inc stocks. The insider ownership of SpringWorks Therapeutics Inc is 3.18%, while institutional ownership is 97.79%. The most recent insider transaction that took place on Mar 03 ’25, was worth 1,084,592. In this transaction Chief Operating Officer of this company sold 20,000 shares at a rate of $54.23, taking the stock ownership to the 169,712 shares. Before that another transaction happened on Mar 03 ’25, when Company’s Chief Executive Officer sold 49,000 for $54.24, making the entire transaction worth $2,657,656. This insider now owns 954,869 shares in total.
SpringWorks Therapeutics Inc (SWTX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 20.99% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
You can see what SpringWorks Therapeutics Inc (SWTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.41, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -0.83 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Looking closely at SpringWorks Therapeutics Inc (NASDAQ: SWTX), its last 5-days average volume was 5.96 million, which is a jump from its year-to-date volume of 4.04 million. As of the previous 9 days, the stock’s Stochastic %D was 34.21%. Additionally, its Average True Range was 1.08.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 47.11%, which indicates a significant increase from 23.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.52% in the past 14 days, which was lower than the 82.71% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.72, while its 200-day Moving Average is $39.94. However, in the short run, SpringWorks Therapeutics Inc’s stock first resistance to watch stands at $46.18. Second resistance stands at $46.26. The third major resistance level sits at $46.30. If the price goes on to break the first support level at $46.06, it is likely to go to the next support level at $46.02. Now, if the price goes above the second support level, the third support stands at $45.94.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
There are 75,323K outstanding shares of the company, which has a market capitalization of 3.47 billion. As of now, sales total 191,590 K while income totals -258,130 K. Its latest quarter income was 49,090 K while its last quarter net income were -83,190 K.
